| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |